The abstract is read at the publisher; the summary is JClub's.
Lipid transfer, load, metabolism, and cellular homeostasis are positioned as upstream drivers of pathology across neurodegenerative diseases, reframing therapeutic development beyond protein aggregation.
- Why it matters: The field has focused heavily on protein aggregation, but accumulating evidence points to lipid dysfunction and related cellular networks as key contributors that could improve stratification and targeting.
- What they did: The work synthesizes neurobiological, genetic, and mechanistic evidence to build an integrated framework emphasizing lipid transport and lysosomal/trafficking networks in cholesterol regulation, glycosphingolipid clearance, endolysosomal function, and neuron–glia lipid exchange.
- The result: Re-centering therapy on correcting lipid imbalances and metabolic dysregulation is proposed to enable more precise clinical trials and combination strategies, potentially complementing or obviating protein-targeted approaches.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.